HOXB13 and posterior cortical atrophy: The relative risk to develop PCa in patients with BRCA 1 mutations has been reported as 1.8-4.5, while the relative risk reported in patients with mutations in BRCA 2 is 23, and patients with HOXB13 mutation have eightfold higher risk 5.